Department of Diagnostics and Public Health, University of Verona, Verona, Italy, Italy
Disclosure information not submitted.
5E-06 - Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in patients with Type 2 Diabetes
Tuesday, August 26, 20259:45 AM - 10:00 AM ET
5F-06 - Randomized clinical trial replication and second-stage study to evaluate the risk of serious infections in biological drug users with psoriatic arthritis/psoriasis using the Italian VALORE distributed database network
